Skip to main content
Premium Trial:

Request an Annual Quote

Arrowhead Acquires IP on Nanosensor Biomolecular Interaction Tech from University of Munich

NEW YORK, May 18 (GenomeWeb News) - Arrowhead Research has acquired intellectual property on nanosensor technology for measuring biomolecular interactions from the Universityof Munich, the company said today.


Arrowhead, based in Pasadena, Calif., said it paid a "de minimus," or insignificant, amount of cash for the patents and patent applications.


The technology, developed by Hermann Gaub, a professor of biophysics at the Center for Nanoscience at the Universityof Munich, relies on single-molecule force spectroscopy and is sensitive enough to detect single base air mismatches of DNA. The patent applications cover parallel assays for placing millions of sensors on a chip.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.